Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Romanos Sklavenitis-Pistofidis

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Hormones (Athens, Greece)|July 10, 2015
Primary hyperparathyroidism and the road to surgery: appraisal of the proceedings of the four international workshops (1990, 2002, 2008, 2014) on primary hyperparathyroidismRomanos Sklavenitis-Pistofidis, Ourania Papaioannou, Kalliopi Kotsa
Nature Medicine|March 5, 2021
Single-cell RNA sequencing: one step closer to the clinicRomanos Sklavenitis-Pistofidis, Gad Getz, Irene Ghobrial
Hemasphere|March 21, 2022
Bone marrow niche in multiple myeloma and its precursor statesRomanos Sklavenitis-Pistofidis, Mark Bustoros, Irene M Ghobrial
Frontiers in Oncology|August 1, 2022
Multiple Myeloma With Amplification of Chr1q: Therapeutic Opportunity and ChallengesRomanos Sklavenitis-Pistofidis, Gad Getz, Irene Ghobrial, et al.
Nature Immunology|May 21, 2021
Inflammatory stromal cells in the myeloma microenvironmentRomanos Sklavenitis-Pistofidis, Nicholas J Haradhvala, Gad Getz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 20, 2019
Reply to F.D. LeonardMark Bustoros, Romanos Sklavenitis-Pistofidis, Jorge J Castillo, et al.
Nature Reviews. Clinical Oncology|January 12, 2022
Single-cell profiling of tumour evolution in multiple myeloma - opportunities for precision medicineAnkit K Dutta, Jean-Baptiste Alberge, Romanos Sklavenitis-Pistofidis, et al.
Leukemia|July 21, 2018
Acute lymphoblastic leukemia as a clonally unrelated second primary malignancy after multiple myelomaIbrahim Aldoss, Marzia Capelletti, Jihye Park, et al.
Blood Advances|April 4, 2019
Citron Rho-interacting kinase silencing causes cytokinesis failure and reduces tumor growth in multiple myelomaIlyas Sahin, Yawara Kawano, Romanos Sklavenitis-Pistofidis, et al.
STAR Protocols|March 4, 2022
Mass cytometry staining for human bone marrow clinical samplesMargaret Hallisey, Jenna Dennis, Charlotte Abrecht, et al.
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Hormones (Athens, Greece)|July 10, 2015
Primary hyperparathyroidism and the road to surgery: appraisal of the proceedings of the four international workshops (1990, 2002, 2008, 2014) on primary hyperparathyroidismRomanos Sklavenitis-Pistofidis, Ourania Papaioannou, Kalliopi Kotsa
Nature Medicine|March 5, 2021
Single-cell RNA sequencing: one step closer to the clinicRomanos Sklavenitis-Pistofidis, Gad Getz, Irene Ghobrial
Hemasphere|March 21, 2022
Bone marrow niche in multiple myeloma and its precursor statesRomanos Sklavenitis-Pistofidis, Mark Bustoros, Irene M Ghobrial
Frontiers in Oncology|August 1, 2022
Multiple Myeloma With Amplification of Chr1q: Therapeutic Opportunity and ChallengesRomanos Sklavenitis-Pistofidis, Gad Getz, Irene Ghobrial, et al.
Nature Immunology|May 21, 2021
Inflammatory stromal cells in the myeloma microenvironmentRomanos Sklavenitis-Pistofidis, Nicholas J Haradhvala, Gad Getz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 20, 2019
Reply to F.D. LeonardMark Bustoros, Romanos Sklavenitis-Pistofidis, Jorge J Castillo, et al.
Nature Reviews. Clinical Oncology|January 12, 2022
Single-cell profiling of tumour evolution in multiple myeloma - opportunities for precision medicineAnkit K Dutta, Jean-Baptiste Alberge, Romanos Sklavenitis-Pistofidis, et al.
Leukemia|July 21, 2018
Acute lymphoblastic leukemia as a clonally unrelated second primary malignancy after multiple myelomaIbrahim Aldoss, Marzia Capelletti, Jihye Park, et al.
Blood Advances|April 4, 2019
Citron Rho-interacting kinase silencing causes cytokinesis failure and reduces tumor growth in multiple myelomaIlyas Sahin, Yawara Kawano, Romanos Sklavenitis-Pistofidis, et al.
STAR Protocols|March 4, 2022
Mass cytometry staining for human bone marrow clinical samplesMargaret Hallisey, Jenna Dennis, Charlotte Abrecht, et al.
Pageof 5